Ingenza announces partnership with Cellugy to investigate the potential of biofabricated cellulose

Industrial biotech specialist Ingenza is delighted to announce that it is collaborating with Cellugy to accelerate the development of its innovative platform for producing biofabricated cellulose.

FDA approves J&J and Legend’s Carvykti for second-line multiple myeloma

The FDA has expanded the label for Johnson & Johnson and Legend Biotech’s multiple myeloma CAR-T therapy to make it a much earlier treatment option

April 7, 2024

CalmiGo Launches Platform to Help Users Manage Anxiety and Track Progress

What You Should Know: – CalmiGo, a pioneer in providing immediate relief and long-term care for anxiety, PTSD, and panic attacks, has unveiled its enhanced

October 10, 2024

AbbVie buys Third Rock’s Celsius for $250M to expand IBD pipeline

As AbbVie continues to tout its next generation of immunology drugs behind Humira, it’s buying an early-stage startup to boost its longer-term prospects in inflammatory

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.